Methotrexate therapy for cesarean section scar pregnancy with and without suction curettage  

Oleh:

Jian-Hua, Wang ; Kai-Hong, XU ; Jun, Lin ; Jian-Yun, Xu ; Rui-Jin, Wu

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 92 no. 04 (Oct. 2009), page 1208-1213.
Topik: Cesarean scar; ectopic pregnancy; methotrexate; curettage; treatment

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2009.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Objective To compare the clinical effects in women with cesarean scar pregnancy (CSP) who were treated with either methotrexate (MTX) regimen only or MTX regimen followed by dilation and curettage (D&C). Design Prospective consecutive clinical cohort study. Setting University hospital for obstetrics, gynecology, and reproductive medicine. Subject(s) Seventy-one cases of CSP. Intervention(s) The subjects were treated with either MTX only (MTX group, 21 cases) or MTX followed by D&C (combined therapy group, 50 cases). Main Outcome Measure(s) Success rates, hysterectomy rates, and time to resolution of serum ß-hCG and the CSP mass were compared between the two groups. Result(s) Compared with the MTX group, the combined therapy group had a shorter time to resolution of the CSP mass and serum ß-hCG. There was no significant difference between the MTX and combined therapy groups regarding success rates (76.2% vs. 90.0%, respectively) and hysterectomy rates (19.0% vs. 8.0%, respectively). Conclusion(s) Both therapies could treat the majority of CSP patients successfully, but the combined therapy resulted in a shorter time of therapy and indicated a more favorable effect.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali